跳至主要内容
临床试验/NCT03830567
NCT03830567已完成不适用

Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 471 人开始时间: 2019年1月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
471
试验地点
1
主要终点
Contraceptive continuation rates

研究概览

简要总结

Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

详细描述

Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription.

This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 51 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women presenting to initiate hormonal contraception at a study pharmacy

排除标准

  • Pregnancy
  • Contraindications to hormonal contraception
  • Under 18 years of age
  • Unable or unwilling to consent

结局指标

主要结局

Contraceptive continuation rates

时间窗: 12 months

Percentage of contraceptive continuation assessed through survey at 12 months among women who present for contraception in pharmacies.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Rodriguez, MD, MPH

Associate Professor

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验